Le Lézard
Classified in: Health, Science and technology
Subject: PDT

Affiliated Dermatologists Notifies of Data Security Incident


MORRISTOWN, N.J., May 23, 2024 /PRNewswire/ -- Affiliated Dermatologists (AD) is providing an update to its May 3 notice of a recent data security incident. At this time, AD is not aware of any misuse of any personal information in connection with this incident.

What Happened?

On March 5, 2024, AD detected it was the target of a cybersecurity attack whereby an unauthorized third party gained access and left a ransom note on AD's network. Upon discovery of this incident, AD immediately disconnected access to the network, alerted its third-party IT provider, and engaged specialized cybersecurity professionals to conduct a forensic investigation into the nature and scope of the incident.

On April 10, 2024, AD's investigation determined that between March 2, 2024 and March 5, 2024, the unauthorized actor obtained access to certain systems and copied data from AD's network, including the personal information of AD patients and employees.

What Information Was Impacted?

AD's investigation has determined that the unauthorized actor may have accessed the following categories of information:

The information involved varies for each individual, and not every category applies in each individual case. 

AD mailed personalized notification letters to the affected individuals on May 23 that detail the specific categories of information that apply in each individual's case.

What Remediation Measures Were Taken?

AD takes the privacy and security of personal information seriously. Since the discovery of the incident, AD has taken steps to further enhance its network security, including implementation of 24-7 network security monitoring, multi-factor authentication for all remote access, and password resets for all accounts on the network.

AD is offering free credit monitoring and identity theft protection services to all potentially-affected individuals. On May 23, AD mailed personalized notification letters to the affected individuals that provide instructions on how to enroll in those services.

What Steps Can Individuals Take?

AD encourages everyone to remain vigilant against incidents of identity theft by reviewing their account statements and monitoring their credit reports for any suspicious activity. Individuals can obtain free copies of their credit reports from the major credit bureaus.

SOURCE Affiliated Dermatologists and Dermatologic Surgeons, P.A.


These press releases may also interest you

at 03:20
Calliditas Therapeutics AB (STO: CALTX) ("Calliditas") today announces that its partner Viatris Pharmaceutical Japan G.K. ("Viatris") has initiated a phase III clinical trial in Japan with Nefecon, named VR-205 in the Japanese market, in Japanese...

at 03:00
Global biotechnology leader CSL Behring today announced that two hemophilia B patients were treated with the gene therapy HEMGENIX® (etranacogene dezaparvovec) at Hemophilia Treatment Centers in France. This milestone achievement makes HEMGENIX® the...

at 02:30
SOPHiA GENETICS , a cloud-native healthcare technology company and a global leader in data-driven medicine, today announced that Dhiti Omics Technologies, a precision molecular diagnostics service provider in India, is live on the SOPHiA...

at 01:15
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the Phase II/III SKYSCRAPER-06 study, evaluating tiragolumab plus Tecentriq® (atezolizumab) and chemotherapy versus pembrolizumab and chemotherapy as an initial...

at 01:05
BenevolentAI ("BenevolentAI" or the "Company") (Euronext Amsterdam: BAI), a leader in applying advanced AI to accelerate biopharma drug discovery, announces the appointment of Deutsche Numis as the Company's Financial and Capital Markets Adviser,...

3 jui 2024
YOUR LEGAL RIGHTS MAY BE AFFECTED There is a proposed settlement in a class-action lawsuit filed against Pfizer Inc., Pfizer Ireland Pharmaceuticals, Warner-Lambert Company, and Warner-Lambert Company LLC (collectively, "Pfizer") and Ranbaxy Inc.,...



News published on and distributed by: